pioglitazone has been researched along with Mood Disorders in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.
Excerpt | Relevance | Reference |
---|---|---|
"Mood disorders and type 2 diabetes mellitus (T2DM) are prevalent conditions that often co-occur." | 3.01 | Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses. ( Fabbri, C; Fanelli, G; Possidente, C; Serretti, A, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Possidente, C | 1 |
Fanelli, G | 1 |
Serretti, A | 1 |
Fabbri, C | 1 |
1 review available for pioglitazone and Mood Disorders
Article | Year |
---|---|
Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses.
Topics: Depressive Disorder, Major; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Mood Disorders; | 2023 |